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Neurological manifestations of gluten sensitivity (epilepsy,
cerebellar ataxia and peripheral neuropathy) are frequent and
probably linked to an immunological attack to nervous tissues
accompanied by neurodegenerative changes.1
A consensus document on new nomenclature and classiﬁcation
of gluten-related disorders identiﬁed celiac disease (CD), wheat
allergy and non-celiac gluten sensitivity (NCGS), that neither
meets the diagnostic criteria for CD nor those for wheat allergy.1,2
Currently there are no speciﬁc biomarkers for NCGS, and the
diagnosis is based on exclusion criteria.
NCGS incorporates a wide range of intestinal symptoms and of
extra-intestinal symptoms, (headaches, lethargy and tiredness,
attention deﬁcit hyperactivity syndrome, autism, schizophrenia,
muscular disturbances and bone and joint pain).1
The introduction of a gluten-free diet improves epilepsy in
patients with conﬁrmed or silent CD.3,4 However, no studies have
reported epilepsy in patients with NCGS. We describe a two-year-
old boy who developed a neurological dysfunction with drug-
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In September 2009, a two-year-old boy with unremarkable
perinatal history, normal psychomotor development and a mild
delay of language presented a ﬁrst generalized tonic–clonic
seizure. There was no family history of neurological diseases or
epilepsy. Neurological examination and electroencephalogram
(EEG) were normal. In August 2010, the boy presented a second
seizure characterized by continuous blinking, eyes turned upward,
and tonic–clonic movements of the upper and lower limbs; EEG
during wakefulness or sleep and neurological examination
continued to be normal. In a few weeks, epilepsy aggravated
and daily polymorphic seizures (generalized tonic–clonic, myo-
clonic-astatic and absence seizures) appeared, suggesting a
diagnosis of myoclonic astatic epilepsy.
The EEG began to show generalized spike-waves followed by
high amplitude slow waves, mixed with spikes, over the anterior
and central-parietal regions (Fig. 1A).
In October 2010, the child underwent brain MRI study that
was normal. His general examination was unremarkable, but
food allergies to dust mites, eggplant, tomato, potato, pepper and
corn were found. Neurocognitive development was normal
(developmental quotient = 96) but with a mild decline in
language skills.
Antiepileptic drug therapy was started using clobazam,
valproate, and ethosuximide. He continued to have seizures with
worsening of behavior, irritability, and motor incoordination.
Different antiepileptic drugs (AEDs) (lamotrigine, topiramate,
levetiracetam) were added/substituted without any improvement.
Complete neurometabolic and genetic tests and screening for the
presence of the candidate gene SCN1A were negative.
Because of the resistance to all AEDs administered, we
suggested a gastroenterologic evaluation, suspecting gluten
hypersensitivity based on the presence of aphthae. Endomysial,
anti-gliadin and anti-transglutaminase antibodies, IGE and IGA
levels were within the normal range. Also the skin prick test for
wheat allergy resulted negative. An esophagogastroduodenoscopy
(EGD) with duodenal biopsy was planned but the parents deniedserved.
Fig. 1. (A) EEG during sleep showing generalized spike-waves followed by high-amplitude slow waves, mixed with spikes, over the frontal and central-parietal regions. (B)
Normalization of the EEG during sleep six months after the introduction of a gluten-free diet.
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DQ8 (DQA1*03, DQB1*03:02). Based on this ﬁnding we decided to
adopt a gluten-free diet; informed consent was asked to the
parents to begin the diet and, after, to withdraw AEDs. After two
weeks, a gradual reversal of the clinical condition started: seizure
frequency and intensity decreased, the child made progress inlanguage and socialization with a decrease of hyperactive and
aggressive behavior. Concurrently, in a few months the EEG
showed a signiﬁcant improvement with almost complete normal-
ization. In November 2011, after 6 months from the beginning of
the gluten-free diet, according to the clinical beneﬁts, we started to
reduce the dosage of AEDs till their complete withdrawal, in three
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parents denied the authorization. The boy did not have seizures,
the EEG normalized and this condition persisted at follow-up, two
years later (Fig. 1B).
3. Discussion
To our knowledge this is the ﬁrst description of a child with
drug-resistant epilepsy, language delay and aphthae in whom a
gluten-free diet brought complete resolution of the seizures,
normalization of the EEG, and a signiﬁcant improvement in speech
organization, even after the withdrawal of all antiepileptic drugs.
Our patient showed no intestinal or extraintestinal symptoms, the
only symptoms related to gastrointestinal discomfort were small
whitish eruptions on the mouth and tongue, recognized as aphthae
but not accompanied by fever, colic, or diarrhea. After the
exclusion of the different causes of epilepsy, we tested the child
for a CD but antibodies to gliadin, endomysium and transgluta-
minases were negative. HLA typing however showed the presence
of the heterodimer DQ8 that allowed us to try a gluten-free diet,
even without the diagnostic support of intestinal biopsy. The
marked improvement of both epilepsy and language soon after the
gluten-free diet that persisted even after the withdrawal of all
antiepileptic drugs, lead us to hypothesize a NCGS neurological
disease in our patient.
The clinical-EEG picture in this boy can be suggestive of
mycolonic absence epilepsy or epileptic encephalopathy with
atypical seizures and drop attacks. Dravet syndrome has been
excluded for the clinical picture, seizure type (never presented
with febrile seizures), EEG features and also the SCNA1 test was
negative. Furthermore, several studies have shown a relationship
between epilepsy and occult CD but these studies included
patients that had epilepsy and after were discovered to be affected
by CD.3,4
Our study has limitations: we could not perform intestinal
biopsy (however, often the endoscopy and biopsy result normal in
NCGS) nor gluten challenge because of the parents’ refusal.
The consequence of this report could be the indication of a
systematic screening for CD in all epileptic patients but obviouslythis is not practical or cost-effective; nevertheless, it seems
reasonable to screen those with intractable seizures. According to
this vision, we suggest to screen children with drug-resistant
epilepsy for CD and, if negative, to evaluate HLA typing for the
presence of heterodimer DQ2 or DQ8. These HLA genes are found in
higher frequency in children with CD than in the general
population. Although they are not diagnostic because 25–40% of
the population has positive results, positive DQ2 or DQ8 in young
children might be a marker of neurologic involvement of gluten
sensitivity and could reﬂect an increased likelihood for the
development of refractory seizures at early ages and, presumably,
CD at later ages.
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